BZPEERReading, trust and collaboration for research
Menu

Discover

GraphFollow connections around a paper, topic or saved view.

Workspaces

HomePick up where your research flow left off.InboxHandle requests, replies and notifications from one place.CollectionsCurate reading lists, evidence sets and shareable dossiers.ResearchSee your private provenance graph, trail and imports.CollaborationMove from discovery into focused discussion rooms.PublishDraft, preview and publish full-text research articles.

Network

ExpertsFind specialists worth following or asking for help.CommunitiesJoin research circles organized around shared work.PartnersSee external organizations active around the same topics.

Opportunities

ListingsBrowse roles, calls and collaborations with clearer fit signals.

Account

Log inReturn to your reading and collaboration workspace.Create accountStart saving work, following people and joining teams.
Log inCreate account

Researcher profile

Sébastien Benzekry

Sébastien Benzekry contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate
Quantitative MethodsTissues and Organsmath.AP

Trust snapshot

Quick read

Trust 17 - UnverifiedVerification L1Unclaimed author
4works
0followers
3topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

4 published item(s)

preprint2026arXiv

Mechanistic Learning for Survival Prediction in NSCLC Using Routine Blood Biomarkers and Tumor Kinetics

Background Predicting overall survival (OS) in non-small cell lung cancer (NSCLC) is essential for clinical decision-making and drug development. While tumor and blood test markers kinetics are intrinsically linked, their joint dynamics and relationship to OS remain unknown. Methods We developed a mechanistic model capturing the interplay between tumor (T) burden and three key blood markers kinetics: albumin (A), lactate dehydrogenase (L), and neutrophils (N), through coupled differential equations (termed TALN-k). This model was enhanced with a machine learning framework (TALN-kML) for OS prediction. The model was trained and validated on clinical trial data from NSCLC patients treated with atezolizumab in monotherapy (N = 862 patients) or combination therapy (N = 1,115). Model parameters were estimated using nonlinear mixed-effects modelling, and survival predictions were assessed using individual and trial level metrics. Results TALN-k successfully described individual and population-level marker kinetics, revealing complex interactions between tumor and blood markers, and improving corrected BIC and log-likelihood metrics by a significant margin of previous empirical state-of-the-art models. Feature selection methods also highlighted valuable predictive parameters, indicatives of good or poor prognosis. The TALN-kML model outperformed empirical, uncoupled models, achieving improved C-index (0.74 $\pm$ 0.02 vs 0.72 $\pm$ 0.03), 12-months AUC (0.83 $\pm$ 0.004 vs 0.79 $\pm$ 0.05), and accuracy (0.77 $\pm$ 0.03 vs 0.76 $\pm$ 0.05) in OS prediction. Conclusion Our mechanistic learning approach allows for an interpretable model, which improves on longitudinal data description and on survival prediction in NSCLC by jointly integrating tumor and blood markers kinetics. This methodology offers a promising avenue for both personalized treatment strategies and drug development optimization.

0 citations0 reviewsNo code linkedOpen access
preprint2021arXiv

Asymptotic analysis of a biphase tumor fluid flow. The weak coupling case

The aim of this paper is to investigate the asymptotic behavior of a biphase tumor fluid flow derived by 2-scale homogenisation techniques in recent works. This biphase fluid flow model accounts for the capillary wall permeability, and the interstitial avascular phase, both being mixed in the limit homogenised problem. When the vessel walls become more permeable, we show that the biphase fluid flow exhibits a boundary layer that makes the computation of the full problem costly and unstable. In the limit, both capillary and interstitial pressures coincide except in the vicinity of the boundary where different boundary conditions are applied. Thanks to a rigorous asymptotic analysis, we prove that the solution to the full problem can be approached at any order of approximation by a monophasic model with appropriate boundary conditions on the tumor boundary and appropriate correcting terms near the boundary are given. Numerical simulations in spherical geometry illustrate the theoretical results.

0 citations0 reviewsNo code linkedOpen access
preprint2014arXiv

Classical Mathematical Models for Description and Prediction of Experimental Tumor Growth

Despite internal complexity, tumor growth kinetics follow relatively simple macroscopic laws that have been quantified by mathematical models. To resolve this further, quantitative and discriminant analyses were performed for the purpose of comparing alternative models for their abilities to describe and predict tumor growth. For this we used two in vivo experimental systems, an ectopic syngeneic tumor (Lewis lung carcinoma) and an orthotopically xenografted human breast carcinoma. The goals were threefold: to 1) determine a statistical model for description of the volume measurement error, 2) establish the descriptive power of each model, using several goodness-of-fit metrics and a study of parametric identifiability, and 3) assess the models ability to forecast future tumor growth. Nine models were compared that included the exponential, power law, Gompertz and (generalized) logistic formalisms. The Gompertz and power law provided the most parsimonious and parametrically identifiable description of the lung data, whereas the breast data were best captured by the Gompertz and exponential-linear models. The latter also exhibited the highest predictive power for the breast tumor growth curves, with excellent prediction scores (greater than 80$\%$) extending out as far as 12 days. In contrast, for the lung data, none of the models were able to achieve substantial prediction rates (greater than 70$\%$) further than the next day data point. In this context, adjunction of a priori information on the parameter distribution led to considerable improvement of predictions. These results not only have important implications for biological theories of tumor growth and the use of mathematical modeling in preclinical anti-cancer drug investigations, but also may assist in defining how mathematical models could serve as potential prognostic tools in the clinical setting.

0 citations0 reviewsNo code linkedOpen access
preprint2014arXiv

Global Dormancy of Metastases Due to Systemic Inhibition of Angiogenesis

Autopsy studies of adults dying of non-cancer causes have shown that virtually all of us possess occult, cancerous lesions. This suggests that, for most individuals, cancer will become dormant and not progress, while only in some will it become symptomatic disease. Meanwhile, it was recently shown in animal models that a tumor can produce both stimulators and inhibitors of its own blood supply. To explain the autopsy findings in light of the preclinical research data, we propose a mathematical model of cancer development at the organism scale describing a growing population of metastases, which, together with the primary tumor, can exert a progressively greater level of systemic angiogenesis-inhibitory influence that eventually overcomes local angiogenesis stimulation to suppress the growth of all lesions. As a departure from modeling efforts to date, we look not just at signaling from and effects on the primary tumor, but integrate over this increasingly negative global signaling from all sources to track the development of total tumor burden. This in silico study of the dynamics of the tumor/metastasis system identifies ranges of parameter values where mutual angio-inhibitory interactions within a population of tumor lesions could yield global dormancy, i.e., an organism-level homeostatic steady state in total tumor burden. Given that mortality arises most often from metastatic disease rather than growth of the primary per se, this finding may have important therapeutic implications.

0 citations0 reviewsNo code linkedOpen access